PT-141: a second cyclic melanocortin analogue

Structurally this sits one step from Melanotan II: the same cyclic seven-residue scaffold, differing at one position. That single change is what a report has to resolve, and the two masses are not far apart.

Research-use scope. This page describes a laboratory research material and its analytical documentation. It is not for use in people or animals, contains no handling, preparation, or procedural guidance, and makes no claim that this material is safe or effective for any purpose. PT-141 is supplied here for laboratory research only.

What it is, and what it is next to

PT-141, also called bremelanotide, is a cyclic peptide of seven residues built on the same melanocortin scaffold as Melanotan II. The two are close structural relatives: the ring is formed the same way, the chain length is the same, and they differ at one position, where PT-141 carries a free acid in place of the amide found on its relative.

PropertyValueWhere it is confirmed
StructureCyclic, closed by a lactam bridgeSynthesis record
Residue count7Synthesis record
Approximate massnear 1,025 g/molCertificate of analysis
Relation to Melanotan IIDiffers at one terminal positionPublished chemistry
Physical form suppliedLyophilized solidLabel and batch record

The masses of the two compounds are close. That is precisely why the stated molecular formula on a report is worth more than a rounded mass for either of them, and why a certificate should name the compound it describes rather than leaving it to the listing.

The same 18-dalton question

Because this is a cyclic peptide, the check described in detail for its relative applies unchanged: closing the ring releases a molecule of water, so the uncyclised linear precursor weighs about 18 more than the finished cyclic product. An identity result matching the calculated cyclic mass confirms the ring closed; a result 18 higher indicates open-chain material.

Two cyclic compounds in the same catalogue with the same structural check is a useful thing to internalise: for any lactam-bridged peptide, the identity line is doing structural work, not just confirming a formula.

What else a report should show

Storage of the lyophilized solid

Supplied as a freeze-dried solid, governed by temperature and moisture. The lactam ring is a stable covalent bond and is not the fragile part of the molecule; the tryptophan residue makes opaque storage worthwhile.

Stability is a documented property rather than an assumed one: a laboratory establishes it by holding material under defined conditions and re-analysing at intervals. Where a retest date is stated, the question worth asking is what data supports it. See storing lyophilized research materials.

What the published literature covers

The research record is preclinical and clinical in parts, covering melanocortin receptor pharmacology, receptor subtype selectivity, and animal models. A substantial share of the literature is structure-activity chemistry comparing this compound with its close relative — studies of how the single terminal difference changes receptor behaviour — which is why that difference rather than the compound's effects is the substance of this page.

The compound has not completed the regulatory process that would establish safety or efficacy for any medical indication, and findings in animal models and cell culture do not transfer automatically to other species. Arctic Lab Supply does not publish research conclusions, recommend applications, or provide guidance on experimental design.

On Arctic Lab Supply reports. Every published report is listed in the batch COA library with its certificate number and verification link. The report for the lot you receive is the one that governs; where an earlier lot's figures differ, the lot-specific report is authoritative.

Related documentation